These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16598543)

  • 1. [Diabetes mellitus and coronary artery disease--a high risk combination].
    Schächinger V; Britten MB; Zeiher AM
    Clin Res Cardiol; 2006 Jan; 95 Suppl 1():i18-26. PubMed ID: 16598543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting.
    Aronson D; Edelman ER
    Rev Endocr Metab Disord; 2010 Mar; 11(1):75-86. PubMed ID: 20221852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting.
    Kassaian SE; Goodarzynejad H; Boroumand MA; Salarifar M; Masoudkabir F; Mohajeri-Tehrani MR; Pourhoseini H; Sadeghian S; Ramezanpour N; Alidoosti M; Hakki E; Saadat S; Nematipour E
    Cardiovasc Diabetol; 2012 Jul; 11():82. PubMed ID: 22805289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of hemoglobin A1C levels in patients with diabetes mellitus undergoing percutaneous coronary intervention with stent implantation.
    Lemesle G; Bonello L; de Labriolle A; Maluenda G; Syed AI; Collins SD; Ben-Dor I; Torguson R; Kaneshige K; Xue Z; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
    Am J Cardiol; 2009 Jul; 104(1):41-5. PubMed ID: 19576319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes and coronary revascularization.
    Flaherty JD; Davidson CJ
    JAMA; 2005 Mar; 293(12):1501-8. PubMed ID: 15784875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Significance of Relative Hyperglycemia after Percutaneous Coronary Intervention in Patients with and without Recognized Diabetes.
    Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
    Curr Vasc Pharmacol; 2021; 19(1):91-101. PubMed ID: 32183677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycaemic control and restenosis after percutaneous coronary interventions in patients with diabetes mellitus: a report from the Insulin Diabetes Angioplasty study.
    Hage C; Norhammar A; Grip L; Malmberg K; Sarkar N; Svane B; Rydén L
    Diab Vasc Dis Res; 2009 Apr; 6(2):71-9. PubMed ID: 20368196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bypass surgery versus percutaneous coronary intervention in patients with diabetes mellitus].
    Dörr R
    Herz; 2010 May; 35(3):182-90. PubMed ID: 20467930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus-eluting stents.
    Nikolsky E; Holmes DR; Mehran R; Dangas G; Schampaert E; Morice MC; Schofer J; Sousa JE; Fahy M; Na Y; Donohoe DJ; Moses JW; Leon MB
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):896-906. PubMed ID: 18498145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Silent" Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents: The BIO-RESORT Silent Diabetes Study.
    von Birgelen C; Kok MM; Sattar N; Zocca P; Doelman C; Kant GD; Löwik MM; van der Heijden LC; Sen H; van Houwelingen KG; Stoel MG; Louwerenburg JHW; Hartmann M; de Man FHAF; Linssen GCM; Doggen CJM; Tandjung K
    JACC Cardiovasc Interv; 2018 Mar; 11(5):448-459. PubMed ID: 29454724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of drug-eluting stents among insulin-treated diabetic patients: a report from the National Heart, Lung, and Blood Institute Dynamic Registry.
    Mulukutla SR; Vlachos HA; Marroquin OC; Selzer F; Holper EM; Abbott JD; Laskey WK; Williams DO; Smith C; Anderson WD; Lee JS; Srinivas V; Kelsey SF; Kip KE
    JACC Cardiovasc Interv; 2008 Apr; 1(2):139-47. PubMed ID: 19212456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Outcomes in Patients With Diabetes Mellitus Related to Prolonging Clopidogrel More Than 12 Months After Coronary Stenting.
    Thukkani AK; Agrawal K; Prince L; Smoot KJ; Dufour AB; Cho K; Gagnon DR; Sokolovskaya G; Ly S; Temiyasathit S; Faxon DP; Gaziano JM; Kinlay S
    J Am Coll Cardiol; 2015 Sep; 66(10):1091-101. PubMed ID: 26337986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Revascularization of coronary artery disease in diabetes mellitus].
    Wexberg P; Weidinger F
    Wien Med Wochenschr; 2010 Jan; 160(1-2):40-3. PubMed ID: 20229160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus.
    Noman A; Balasubramaniam K; Alhous MHA; Lee K; Jesudason P; Rashid M; Mamas MA; Zaman AG
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1195-1204. PubMed ID: 28029209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosylated hemoglobin is a predictor of major adverse cardiac events after drug-eluting stent implantation in patients with diabetes mellitus.
    Ueda H; Mitsusada N; Harimoto K; Miyawaki M; Yasuga Y; Hiraoka H
    Cardiology; 2010; 116(1):51-7. PubMed ID: 20453503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen is associated with glucose metabolism and cardiovascular outcomes in patients with coronary artery disease.
    Liu SL; Wu NQ; Shi HW; Dong Q; Dong QT; Gao Y; Guo YL; Li JJ
    Cardiovasc Diabetol; 2020 Mar; 19(1):36. PubMed ID: 32192491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study.
    Funamizu T; Iwata H; Nishida Y; Miyosawa K; Doi S; Chikata Y; Shitara J; Endo H; Wada H; Naito R; Ogita M; Dohi T; Kasai T; Okazaki S; Isoda K; Miyauchi K; Daida H
    Cardiovasc Diabetol; 2020 Feb; 19(1):21. PubMed ID: 32070335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Coronary angioplasty in diabetic patients. Current and future perspectives].
    Alonso JJ; Durán JM; Gimeno F; Ramos B; Serrador A; Fernández-Avilés F
    Rev Esp Cardiol; 2002 Nov; 55(11):1185-200. PubMed ID: 12423576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Coronary revascularization of coronary artery disease in patients with diabetes].
    Tsuboi S; Miyauchi K
    Nihon Rinsho; 2011 Feb; 69(2):329-34. PubMed ID: 21387685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, Predictors, and Clinical Outcomes of New-Onset Diabetes Mellitus after Percutaneous Coronary Intervention with Drug-Eluting Stent.
    Chun KH; Im E; Kim BK; Shin DH; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    J Korean Med Sci; 2017 Oct; 32(10):1603-1609. PubMed ID: 28875603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.